We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

102 hedge funds and large institutions have $121M invested in VanEck Biotech ETF in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 30 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more call options, than puts

Call options by funds: $239K | Put options by funds: $211K

1.54% less ownership

Funds ownership: 29.97% → 28.43% (-1.5%)

6% less funds holding

Funds holding: 108 → 102 (-6)

8% less capital invested

Capital invested by funds: $132M → $121M (-$10.2M)

23% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 13

37% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 30

Holders
102
Holders Change
-6
Holders Change %
-5.56%
% of All Funds
1.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
19
Reduced
30
Closed
13
Calls
$239K
Puts
$211K
Net Calls
+$28K
Net Calls Change
+$261K

Top Buyers

Rank Fund Capital Flow
1
PGFC
Peapack-Gladstone Financial Corp
New Jersey
+$4.36M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.9M
3
Citadel Advisors
Citadel Advisors
Florida
+$1.79M
4
JMPWA
JP Morgan Private Wealth Advisors
California
+$1.59M
5
LJAC
L.J. Altfest & Co
New York
+$846K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$4.75M
2
CCA
Conservest Capital Advisors
Pennsylvania
-$3.49M
3
Morgan Stanley
Morgan Stanley
New York
-$1.88M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.64M
5
LPL Financial
LPL Financial
California
-$1.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
SPIA
101
Steward Partners Investment Advisory
New York
$3K +$2.72K +18 New
BHWM
102
Beaird Harris Wealth Management
Texas
$1K +$1.06K +7 New
Bank of Montreal
103
Bank of Montreal
Ontario, Canada
$35 -$213K -1,406 -86%
Cetera Investment Advisers
104
Cetera Investment Advisers
Illinois
– -$397K -2,726 Closed
MWA
105
MFA Wealth Advisors
Pennsylvania
– -$262K -1,800 Closed
HFAS
106
Hummer Financial Advisory Services
Illinois
– -$206K -1,410 Closed
HWM
107
Howard Wealth Management
Connecticut
– -$203K -1,398 Closed
SWM
108
SeaCrest Wealth Management
New York
– -$48K -330 Closed
CAPTRUST Financial Advisors
109
CAPTRUST Financial Advisors
North Carolina
– -$12K -79 Closed
CPFP
110
Clear Perspectives Financial Planning
Ohio
– -$8K -55 Closed
AA
111
Ancora Advisors
Ohio
– -$7K -50 Closed
SIAP
112
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
– -$5K -34 Closed
CFD
113
Creative Financial Designs
Indiana
– -$4K -25 Closed
VRM
114
Vectors Research Management
New York
– -$2K -16 Closed
1 2 3 4
5

BBH Hedge Fund Activity: Q3 2022 in Review

102 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2022, worth a combined $121M — down 7.8% from $132M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of BBH and 10 opened new positions — a net loss of 3 holders — while 30 trimmed existing stakes and 19 added.

The largest buyer was Peapack-Gladstone Financial Corp, opening a new position worth an estimated $4.36M. The largest seller was Bank of America, cutting an estimated $4.75M.

  • 102 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2022, down from 108 in Q2 2022.
  • Funds reported $121M of VanEck Biotech ETF stock for Q3 2022, down 7.8% quarter-over-quarter.
  • 10 funds opened new VanEck Biotech ETF positions in Q3 2022 and 13 closed out, a net change of -3 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2022 was Peapack-Gladstone Financial Corp, an estimated $4.36M added.
  • The largest VanEck Biotech ETF seller in Q3 2022 was Bank of America, an estimated $4.75M sold.

Based on aggregated 13F filings for Q3 2022.